Back to Blog April 04, 2015 in


Navigate all the resources featured in the Landscape Guide by geographic location, industry sector, and organization type. Landscape Guide
Everything you need to know to make a meaningful first connection can be found in our 2021-22 Landscape Guide! Download the Guide

2023 MVCA Research Report

Our state's entrepreneurial economy hinges on our ability to provide capital to our high-growth, high-potential companies. Download the Report

About HistoSonics

HistoSonics, Inc., located in Ann Arbor, Michigan, began operations in December 2009 when the Company received investor financing and technology was exclusively licensed from the University of Michigan.

Histotripsy, developed at the University of Michigan, is a non-invasive soft tissue ablation modality that mechanically homogenizes target tissue resulting in complete cellular destruction.  As a non-thermal modality, histotripsy ablates tissue with no thermal injury.  The liquefied tissue is absorbed or voided without remnants or scarring.

The first histotripsy clinical application will be an office/clinic based system for non-invasive, image-guided benign prostate hyperplasia (BPH) treatment.